Teva inks trailblazing cannabis pact with Israel's Syqe Medical

slimvictor

Bluelight Crew
Joined
Dec 29, 2008
Messages
6,477
Location
"Darkness cannot be dissipated with more darkness.
Teva has struck a new marketing agreement, and it’s one that’ll help the Israeli drugmaker blaze a new trail in the drug industry.

The pharma has inked a pact that will make it the only distributor in Israel of local company Syqe Medical’s cannabis inhaler, the companies said Monday, without disclosing any financial data on the agreement. Teva will also help Syqe set up a support and instruction team of nurses for patients and healthcare providers.

As of this year, Israel boasted about 26,000 medical cannabis consumption licenses—a figure that’s expected to double by 2018, Israeli newspaper Globes reports. And with licensed patients spending an average $100 per month on cannabis, the revenue potential is there for Teva if the company can get the inhaler selling.

cont at
http://www.fiercepharma.com/marketing/teva-inks-trailblazing-cannabis-pact-israel-s-syqe-medical
 
They're not really clear but every registered patient in Israel pays the same amount (I thought it was $15) no matter how much cannabis you receive. It's because it's so cheap to produce only the profit margin is shifting, even for the highest consumers.

EDIT:
Here's where I read it. The owner of Tikun Olam, the largest provider in Israel, specified that every patient pays 370 scheckels a month, regardless of prescription amount. Current that's about 96 dollars. The issue here is that if your inhaler is expensive to produce or you want a high co-pay you're fucked because it still has to fit in that $96. Fuck cannabis profiteers.
 
Top